The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorShanghai Mental Health Center

About this trial

This study aims to evaluate the efficacy of Temporal Interference (TI) stimulation in treating patients with obsessive-compulsive disorder (OCD) and to explore its potential neural mechanisms using magnetic resonance imaging (MRI) and electroencephalography (EEG).

Eligibility criteria

Qualifiers

18-50 years old

Diagnosis of OCD per DSM-5

Y-BOCS score ≥20

Have a documented history of at least two adequate trials of selective serotonin reuptake inhibitors (SSRIs). If currently receiving SSRI treatment, the dosage must be stable for at least 8 weeks prior to enrollment

Disqualifiers

Any DSM-5 diagnosis other than OCD (except OCPD)

OCD symptoms too severe to complete assessments

Received electroconvulsive therapy (ECT) within the past 6 months

Received other forms of neuromodulation within the past 2 months(see Item 3 for ECT)

Trial design

Treatments tested in this trial

  • TI stimulation device (nerviox-1000)

Treatment groups

18 Participants
are divided into 3 treatment groups

Sponsors and collaborators